ATYR PHARMA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.49 EUR | +3.47% |
|
-5.88% | +11.63% |
| Mar. 15 | RBC Cuts Price Target on aTyr Pharma to $16 From $19, Keeps Outperform Rating, Speculative Risk Qualifier | MT |
| Mar. 14 | Transcript : ATyr Pharma, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Chart calendar aTyr Pharma, Inc.
b7.IfRX5ecM8bMYycXAfbsu4Ilcs30jnJpm4dbNl0HwDPU.WbgkkatVo4RB8aepCc8Dg-Au2TVUzOhTqeWf-AWcXMNjpCSkgkCkgWuhjA~dc326ed070c103b9abc6a97b9aa88106
Upcoming events on aTyr Pharma, Inc.
Past events on aTyr Pharma, Inc.
| 2024-04-16 | Piper Sandler Spring Biopharma Symposium |
| 2024-04-04 10:30 am | Evercore ISI Diamonds in the Rough Webinar Day |
| 2024-03-23 | Fibroblast Growth Factors in Development and Disease Gordon Research Conference |
| 2024-03-14 05:00 pm | Q4 2023 Earnings Call |
| 2024-03-14 04:00 pm | Q4 2023 Earnings Release |
| 2024-01-30 09:30 pm | Keystone Symposium - Poster No: 2027 |
| 2024-01-29 10:30 pm | Keystone Symposium - Poster No: 1012 |
| 2023-12-03 | Noble Capital Markets Emerging Growth Equity Conference |
| 2023-11-30 12:00 pm | Piper Sandler Healthcare Conference - Fireside Chat |
| 2023-11-15 10:30 am | Jefferies London Healthcare Conference |
| 2023-11-13 12:00 pm | American College of Rheumatology Conference - Poster Number: 1322 |
| 2023-11-08 | Q3 2023 Earnings Release |
| 2023-09-13 09:30 am | H.C. Wainwright Global Investment Conference |
| 2023-09-08 | European Respiratory Society International Congress |
| 2023-08-09 04:00 pm | Q2 2023 Earnings Release |
| 2023-06-20 05:55 am | World Association for Sarcoidosis and Other Granulomatous Disorders Conference |
| 2023-06-08 03:30 pm | Jefferies Global Healthcare Conference |
| 2023-05-23 01:30 pm | American Thoracic Society International Conference |
| 2023-05-23 11:30 am | American Thoracic Society International Conference |
| 2023-05-22 03:15 pm | American Thoracic Society International Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,42 0,43 -2.26% | 10,5 8,53 22.52% | 0,00 2,52 - | 10,4 0,25 4054.4% | 0,35 0,41 -14.89% | 2,63 |
|
EBITDA Million USD | Released Forecast Spread | -22,3 -22,9 2.43% | -15,3 -17,8 13.81% | -33,5 -34,9 3.9% | -46,2 -52,2 11.55% | 0,00 -55,3 - | -71,7 |
|
EBIT Million USD | Released Forecast Spread | -23,0 -22,9 -0.39% | -15,9 -19,1 16.58% | -34,0 -33,6 -1.26% | -46,4 -52,5 11.57% | -54,9 -53,3 -3.06% | -66,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,8 -23,3 -1.99% | -16,2 -19,4 16.34% | -33,8 -32,8 -3.07% | -45,3 -51,7 12.3% | -50,4 -49,6 -1.71% | -63,3 |
|
Net income Million USD | Released Forecast Spread | -23,6 -23,3 -1.3% | -16,2 -19,4 16.37% | -33,8 -32,8 -3.06% | -45,3 -51,7 12.31% | -50,4 -49,5 -1.71% | -63,3 |
|
EPS USD | Released Forecast Spread | -7,03 -6,98 -0.72% | -1,77 -2,17 18.31% | -1,77 -1,79 1.3% | -1,60 -1,82 12.09% | -0,94 -0,94 -0.27% | -0,99 |
| Announcement Date | 26/03/20 | 23/03/21 | 14/03/22 | 09/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,25 8,14 1.35% | 0,00 2,52 - | 0,00 0,17 - | 0,00 2,00 - | 0,00 0,40 - | 10,4 0,25 4054.4% | 0,00 0,36 - | 0,00 0,61 - | 0,35 1,20 -70.58% | 0,00 0,07 - | 0,03 | 0,03 | 2,53 | 0,04 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -4,15 -4,30 3.49% | -8,53 -9,50 10.19% | -12,3 -8,80 -39.74% | -12,5 -10,3 -21.56% | -13,5 -12,7 -6.24% | -7,91 -13,8 42.67% | -12,7 -13,5 5.87% | -13,4 -11,1 -20.69% | -12,4 -10,0 -24.39% | -16,4 | -16,8 | -17,5 | -18,3 | -19,2 | |
|
EBIT Million USD | Released Forecast Spread | -8,64 -7,32 -18.07% | -12,4 -8,84 -39.96% | -12,6 -11,1 -13.88% | -13,5 -13,4 -0.81% | -7,95 -14,0 43.33% | -12,8 -16,4 22.21% | -13,6 -13,3 -2.19% | -12,6 -14,2 11.42% | -16,0 -13,7 -16.87% | -16,2 | -16,7 | -13,8 | -17,6 | -17,3 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,70 -4,30 -9.3% | -8,56 -7,54 -13.53% | -12,2 -8,75 -38.94% | -12,4 -12,4 -0.23% | -13,2 -13,1 -1.45% | -7,52 -13,9 45.83% | -12,0 -15,6 23.42% | -12,3 -12,6 1.81% | -11,3 -12,6 10.13% | -14,8 -13,9 -6.02% | -15,6 | -16,2 | -14,2 | -17,3 | -17,3 |
|
Net income Million USD | Released Forecast Spread | -4,69 -4,30 -9.07% | -8,56 -7,54 -13.51% | -12,2 -8,75 -38.94% | -12,4 -12,4 -0.23% | -13,2 -13,1 -1.45% | -7,52 -13,9 45.84% | -12,0 -15,6 23.42% | -12,3 -12,6 1.84% | -11,3 -12,6 10.13% | -14,8 -13,9 -6.02% | -15,6 | -16,2 | -14,2 | -17,3 | -17,3 |
|
EPS USD | Released Forecast Spread | -0,58 -0,53 -9.43% | -0,31 -0,28 -9.41% | -0,44 -0,33 -32.66% | -0,44 -0,44 0% | -0,46 -0,46 0.54% | -0,26 -0,48 45.83% | -0,29 -0,41 29.61% | -0,22 -0,27 19.71% | -0,20 -0,22 10.11% | -0,25 -0,24 -4.17% | -0,25 | -0,26 | -0,22 | -0,27 | -0,25 |
| Announcement Date | 13/08/20 | 14/03/22 | 09/05/22 | 15/08/22 | 10/11/22 | 09/03/23 | 09/05/23 | 09/08/23 | 09/11/23 | 14/03/24 | - | - | - | - | - |
More events
Past sector events for aTyr Pharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LIFE Stock
- 471A Stock
- Calendar aTyr Pharma, Inc.
